| # | Title | Journal | Year | Citations |
|---|
| 1 | SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) | Molecular Autism | 2013 | 632 |
| 2 | Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication | Molecular Autism | 2010 | 521 |
| 3 | Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses | Molecular Autism | 2017 | 502 |
| 4 | Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia | Molecular Autism | 2017 | 495 |
| 5 | Sex and gender differences in autism spectrum disorder: summarizing evidence gaps and identifying emerging areas of priority | Molecular Autism | 2015 | 413 |
| 6 | Common genetic variants, acting additively, are a major source of risk for autism | Molecular Autism | 2012 | 357 |
| 7 | Measuring autistic traits in the general population: a systematic review of the Autism-Spectrum Quotient (AQ) in a nonclinical population sample of 6,900 typical adult males and females | Molecular Autism | 2015 | 350 |
| 8 | Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder | Molecular Autism | 2013 | 330 |
| 9 | Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders | Molecular Autism | 2016 | 324 |
| 10 | Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial | Molecular Autism | 2012 | 293 |
| 11 | Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study | Molecular Autism | 2011 | 284 |
| 12 | Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency | Molecular Autism | 2013 | 278 |
| 13 | Risk markers for suicidality in autistic adults | Molecular Autism | 2018 | 263 |
| 14 | Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders | Molecular Autism | 2014 | 246 |
| 15 | Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here | Molecular Autism | 2011 | 243 |
| 16 | DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes | Molecular Autism | 2013 | 243 |
| 17 | Defining the broader, medium and narrow autism phenotype among parents using the Autism Spectrum Quotient (AQ) | Molecular Autism | 2010 | 240 |
| 18 | Gender differences in emotionality and sociability in children with autism spectrum disorders | Molecular Autism | 2014 | 215 |
| 19 | An investigation of the ‘female camouflage effect’ in autism using a computerized ADOS-2 and a test of sex/gender differences | Molecular Autism | 2016 | 214 |
| 20 | CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells | Molecular Autism | 2017 | 214 |
| 21 | Fragile X and autism: Intertwined at the molecular level leading to targeted treatments | Molecular Autism | 2010 | 204 |
| 22 | Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder | Molecular Autism | 2016 | 204 |
| 23 | Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model | Molecular Autism | 2015 | 194 |
| 24 | A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism | Molecular Autism | 2011 | 191 |
| 25 | Selection bias on intellectual ability in autism research: a cross-sectional review and meta-analysis | Molecular Autism | 2019 | 185 |
| 26 | The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders | Molecular Autism | 2017 | 183 |
| 27 | Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism | Molecular Autism | 2016 | 179 |
| 28 | Serum microRNA profiles in children with autism | Molecular Autism | 2014 | 174 |
| 29 | The Sensory Perception Quotient (SPQ): development and validation of a new sensory questionnaire for adults with and without autism | Molecular Autism | 2014 | 169 |
| 30 | Autism prevalence in China is comparable to Western prevalence | Molecular Autism | 2019 | 168 |
| 31 | Foetal testosterone and autistic traits in 18 to 24-month-old children | Molecular Autism | 2010 | 162 |
| 32 | SHANK3 haploinsufficiency: a “common” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders | Molecular Autism | 2013 | 152 |
| 33 | Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations | Molecular Autism | 2018 | 152 |
| 34 | Early sex differences are not autism-specific: A Baby Siblings Research Consortium (BSRC) study | Molecular Autism | 2015 | 151 |
| 35 | Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay | Molecular Autism | 2013 | 150 |
| 36 | Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis | Molecular Autism | 2013 | 145 |
| 37 | Comparison of white matter integrity between autism spectrum disorder subjects and typically developing individuals: a meta-analysis of diffusion tensor imaging tractography studies | Molecular Autism | 2013 | 144 |
| 38 | Coping, fostering resilience, and driving care innovation for autistic people and their families during the COVID-19 pandemic and beyond | Molecular Autism | 2020 | 144 |
| 39 | Social and monetary reward processing in autism spectrum disorders | Molecular Autism | 2012 | 143 |
| 40 | Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum | Molecular Autism | 2014 | 141 |
| 41 | Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice | Molecular Autism | 2014 | 137 |
| 42 | CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment | Molecular Autism | 2015 | 135 |
| 43 | Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism | Molecular Autism | 2017 | 135 |
| 44 | Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis | Molecular Autism | 2011 | 132 |
| 45 | Saccadic eye movement abnormalities in autism spectrum disorder indicate dysfunctions in cerebellum and brainstem | Molecular Autism | 2014 | 131 |
| 46 | Test-retest reliability of the ‘Reading the Mind in the Eyes’ test: a one-year follow-up study | Molecular Autism | 2013 | 130 |
| 47 | Autism spectrum disorder and low vitamin D at birth: a sibling control study | Molecular Autism | 2015 | 130 |
| 48 | Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study | Molecular Autism | 2017 | 127 |
| 49 | The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation | Molecular Autism | 2017 | 126 |
| 50 | Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology | Molecular Autism | 2020 | 125 |
